DNA Chip Research Inc. (TYO:2397)

Market Cap	7.39B
Revenue (ttm)	1.09B
Net Income (ttm)	-58.00M
Shares Out	6.77M
EPS (ttm)	-8.58
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,900
Average Volume	13,055
Open	1,090.00
Previous Close	1,090.00
Day's Range	1,090.00 - 1,092.00
52-Week Range	598.00 - 1,100.00
Beta	0.37
RSI	58.17
Earnings Date	May 9, 2025

About DNA Chip Research

DNA Chip Research Inc. develops DNA microarrays in Japan. The company offers research and development, contract research, and diagnostic support services. It offers Tbone EX Kit for Japanese forensic laboratories in police force and universities. The company also develops EGFR (epidermal growth factor receptor) Liquid gene analysis software, a disease diagnosis program for detecting mutations in the gene encoding EGFR using DNA extracted from plasma samples or cancer tissues and determining drug efficacy of EGFR tyrosine kinase inhibitors in pa...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1999
• Employees: 37
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2397

Financial Performance

In 2024, DNA Chip Research's revenue was 1.09 billion, an increase of 122.65% compared to the previous year's 490.00 million. Losses were -58.00 million, -76.61% less than in 2023.